Menu Search

Company Announcements

Mediclinic International PLC

Form 8.3 - Mediclinic International plc

Source: RNS
RNS Number : 5257A
Societe Generale SA
23 September 2022
 

 

This disclosure replaces RNS Number 3455A due to an incorrect booking confirmation. Purchase of 1,679,521 has been removed and replaced with a sale of 1,679,521.

 

 

                                                                                                                                       FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

21/09/2022

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

NO

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.  

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,278,433

1.26

1,682,637

0.23

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

     TOTAL:

9,278,433

1.26

1,682,637

0.23

 

 

All interests and all short positions should be disclosed.

 

                      

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit GBP

Ordinary

Purchase

1,453

4.942

Ordinary

Purchase

219

4.942

Ordinary

Purchase

1,794

4.942

Ordinary

Purchase

460

4.942

Ordinary

Purchase

22,332

4.9497525

Ordinary

Purchase

1,679,521

4.938

Ordinary

Purchase

44

4.936

Ordinary

Purchase

332

4.936

Ordinary

Purchase

342

4.936

Ordinary

Purchase

33

4.944

Ordinary

Purchase

354

4.944

Ordinary

Purchase

131

4.944

Ordinary

Purchase

448

4.946

Ordinary

Purchase

349

4.938

Ordinary

Purchase

376

4.938

Ordinary

Purchase

173

4.938

Ordinary

Purchase

230

4.938

Ordinary

Purchase

199

4.938

Ordinary

Purchase

346

4.942

Ordinary

Purchase

261

4.942

Ordinary

Purchase

151

4.932

Ordinary

Purchase

262

4.94

Ordinary

Purchase

321

4.94

Ordinary

Purchase

508

4.93

Ordinary

Purchase

171

4.942

Ordinary

Purchase

663

4.938

Ordinary

Purchase

154

4.932

Ordinary

Purchase

417

4.938

Ordinary

Purchase

673

4.938

Ordinary

Purchase

303

4.942

Ordinary

Purchase

100

4.93

Ordinary

Purchase

281

4.934

Ordinary

Purchase

412

4.942

Ordinary

Purchase

352

4.932

Ordinary

Purchase

393

4.942

Ordinary

Purchase

318

4.932

Ordinary

Purchase

354

4.94

Ordinary

Purchase

439

4.94

Ordinary

Purchase

476

4.942

Ordinary

Purchase

294

4.936

Ordinary

Purchase

353

4.936

Ordinary

Purchase

244

4.936

Ordinary

Purchase

93

4.934

Ordinary

Purchase

95

4.934

Ordinary

Purchase

355

4.938

Ordinary

Purchase

194

4.938

Ordinary

Purchase

97

4.934

Ordinary

Sale

355

4.94

Ordinary

Sale

2,396

4.938

Ordinary

Sale

744

4.938

Ordinary

Sale

694

4.94

Ordinary

Sale

634

4.932

Ordinary

Sale

414

4.938

Ordinary

Sale

219

4.938

Ordinary

Sale

1,566

4.938

Ordinary

Sale

883

4.95

Ordinary

Sale

500

4.936

Ordinary

Sale

20

4.938

Ordinary

Sale

412

4.938

Ordinary

Sale

496

4.938

Ordinary

Sale

83

4.938

Ordinary

Sale

721

4.938

Ordinary

Sale

2,972

4.95

Ordinary

Sale

7,926

4.95

Ordinary

Sale

12,506

4.95

Ordinary

Sale

1,609

4.95

Ordinary

Sale

1,279

4.938

Ordinary

Sale

1,679,521

4.938


Total Purchases

38,349



Total Sales

1,715,950


 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP






 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

GBP









 

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

 

 

 

 

 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

 

 

 

 

 

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

23/09/2022
Contact name:

Paul Jenkins
Telephone number*:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUBUBUPPGMW